On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

Algae Dynamics Corp. (ADYNF) Collaborates with University of Western Ontario

  • Research finds that higher levels of the brain chemical GABA can reverse negative effects such as schizophrenia and depression
  • Professor Steven Laviolette, who spearheaded the study, hopes that GABA-increasing cannabinoid compounds developed with industrial partners from this research could lead to clinical trials “in the next few years”
  • Algae Dynamics Corp. has signed a collaborative agreement with the University of Western Ontario, giving the company the patent rights to any drugs developed as a result of research

Algae Dynamics Corp. (OTCQB: ADYNF) is in a collaboration agreement with the University of Western Ontario (now rebranded as Western University), which is making international news with its recent study in Nature Scientific Reports (http://dtn.fm/rDG0A). The study found that the negative effects on the adolescent brain from chronic use of tetrahydrocannabinol (THC)-rich marijuana can be reversed by using compounds which increase the amounts of GABA, a chemical and neurotransmitter in the brain.

The article in Nature Scientific Reports is titled “Adolescent THC Exposure Causes Enduring Prefrontal Cortical Disruption of GABAergic Inhibition and Dysregulation of Sub-Cortical Dopamine Function.” The results have been globally reported by Global News, CBC of London, CTV News and UPI.

“What this could mean is that if you are going to be using marijuana, in a recreational or medicinal way, you can potentially combine it with compounds that boost GABA to block the negative effects of THC,” Professor Steven Laviolette of Western University’s Schulich School of Medicine and Dentistry told UPI (http://dtn.fm/Aju1z). Laviolette spearheaded the research study.

Laviolette has focused on the impact of nicotine and opiates and the neurobiology of addiction. He is studying the interface of neurobiology, psychology and emotion by using an integrative combination of behavioral neuropharmacology and vivo neuronal electrophysiology.

THC exposure reduced the GABA in the brain, the study found. GABA regulates hyperactivity in the brain and has been associated with disorders such as schizophrenia. Negative effects developed later in adulthood from use of marijuana with THC include anxiety, depression and schizophrenia. Drugs that increase the amount of GABA could then reverse the impact of THC and eliminate the schizophrenia-linked symptoms, the research found.

“We actually went in, and tried to restore the GABA system by activating GABA receptors directly in the prefrontal cortex,” Laviolette said on the Andrew Lawton radio show in Canada (http://dtn.fm/cImw7). “To our amazement, we found that this reversed those schizophrenia-like symptoms,” he added in an interview with CBC London. He explained that the reversal process can still remain effective many years after the exposure.

“What is important about this study is that not only have we developed a specific mechanism in the prefrontal mechanism for some of the mental health risks associated with adolescent marijuana use,” Laviolette told UPI. “But we have also identified a mechanism to reverse those risks.”

More research is needed to learn if boosting GABA levels would have the same results in humans as in rats, but Laviolette said that, to those people with mental health problems, there may be new hope. Laviolette told CTV News, “I think this is really a promising lead in terms of the potential of developing much safer versions of cannabinoid type drugs.”

Global News added that the next step is combining cannabinoid chemicals with compounds to boost the GABA system. The goal would be to determine better treatments for a range of other mental health disorders, such as anxiety, depression and addiction.

Laviolette, interviewed on the Lawton Show, explained that there is a need now to “dig further” into this research. The result could be more molecular pathways in the future to formulate pharmaceutical compounds with industrial partners, including the process of conducting clinical trials within the next few years. Compounds using cannabinoids may be developed in the future, he said. Cannabidiol can actually have the opposite effect of THC — negating the impact of THC.

He told Lawton that some ‘black market’ marijuana may contain up to 70% THC. THC can also increase dependency levels, he said. The reversal process may suggest larger treatment issues for schizophrenia, regardless of marijuana or THC use.

Forbes reported (http://dtn.fm/Jk7xH) that another study found that chronic cannabis use can result in blunted stress reactivity. That study observed 40 cannabis users and 42 non-users to complete the stress or no-stress conditions of the Maastricht Acute Stress Test (MAST). Saliva samples and cannabis cravings and withdrawal were measured, as part of the study. Results indicated a link between higher stress ratings in non-users. In contrast, chronic cannabis users exhibited blunted stress reactivity, it said. Forbes inferred that marijuana compounds can reduce stress without the dependency of prescription medications.

While preliminary, Forbes explained, the study suggests that marijuana compounds may eventually be used to provide anxiety relief with decreased dependency, fewer side effects and reduced overdose potential.

ADYNF is engaged in the development of products and pharmaceuticals that use cannabis, hemp and algae oils. The development stage company is based in Canada and publicly traded in the U.S. The company has signed a collaboration agreement with the University of Western Ontario, enabling the firm to retain the rights to patents developed in conjunction with the school. Western University is focused on the areas of depression, post-traumatic stress disorder, anxiety and schizophrenia.

According to an ADYNF corporate presentation (http://dtn.fm/1Pd8H), the company is building its intellectual property portfolio in the pharmaceutical field. Its goal is to develop value-added products, supported by strong science and clinical trials, combining the benefits of algae and cannabis oils to enhance efficacy in a unique and patented way.

For more information, visit the company’s website at www.AlgaeDynamics.com

Let us hear your thoughts: Algae Dynamics Corp. Message Board

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.qualitystocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Archives

Select A Month
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • June 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006
  • May 2006
  • April 2006
  • March 2006
  • January 2006
  • December 2005
  • October 2005
  • September 2005
  • Market Basics

    New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

    The Basics

    Newsletter Publishers

    Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

    Register

    Public Companies

    Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

    Get Covered